Stay updated on Nivolumab vs Docetaxel in Squamous NSCLC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab vs Docetaxel in Squamous NSCLC Clinical Trial page.

Latest updates to the Nivolumab vs Docetaxel in Squamous NSCLC Clinical Trial page
- Check4 days agoChange DetectedA revision tag on the page was updated to Revision: v3.6.2, replacing Revision: v3.6.0. This reflects a minor software update rather than any change to the study content.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page now indicates that recruitment is closed with a 'No longer looking for participants' notice, signaling that no further enrollment is open. Navigation labels were updated to include How to Read a Study Record, Common Questions, How to Join a Study, and Intervention/Treatment, the old Intervention / Treatment label was removed, and the revision tag updated to v3.6.0.SummaryDifference0.2%

- Check25 days agoChange DetectedThe page revision tag was updated from v3.5.4 to v3.5.5, indicating a small on-page update. This update does not alter the study content or data.SummaryDifference0.0%

- Check47 days agoChange DetectedThe page's revision tag was updated from v3.5.3 to v3.5.4, indicating a backend/template update; the study details remain unchanged.SummaryDifference0.0%

- Check68 days agoChange DetectedThe Chile site listing for Valparaiso was updated by removing the explicit “Región de Valparaíso” label and switching to a shorter format ("Viña del Mar, Valparaiso, Chile"). The page footer version/revision also changed from v3.5.2 to v3.5.3.SummaryDifference0.3%

- Check75 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

Stay in the know with updates to Nivolumab vs Docetaxel in Squamous NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Docetaxel in Squamous NSCLC Clinical Trial page.